GENERAC HOLDINGS INC. (GNRC) Insider Transactions
Explore official ownership filings, with every record linked to its source.
GNRC · GENERAC HOLDINGS INC.
How to read this data ↗Recent reported activity
Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.
| Transaction / filed | Reporting owner(s) | Code / security | Quantity | Price as filed | Ownership | Source |
|---|---|---|---|---|---|---|
| 2026-10-02Filed 2026-10-06 | Raabe Kyle AndrewOfficer · President, Home Power Gen.Filing contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 05-05-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1, F2 | S Sale (market/private)Common Stock · Non-derivative | 390D | 212.57 | Direct | Form 4 ↗0001437749-26-032193 |
| 2026-10-01Filed 2026-10-02 | Jagdfeld AaronDirector · Officer · Chief Executive OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 12-04-2025 References: F1 | S Sale (market/private)Common Stock · Non-derivative | 5,000D | 206 | Direct | Form 4 ↗0001437749-26-031907 |
| 2026-09-17Filed 2026-09-18 | Taffe Norman POfficer · President Generac HomeFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F2 | M Exercise / conversionStock Option (Right to Buy) · Derivative | 150D | 0 | Direct | Form 4 ↗0001437749-26-030749 |
| 2026-09-17Filed 2026-09-18 | Taffe Norman POfficer · President Generac HomeFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 150D | 229.5 | Direct | Form 4 ↗0001437749-26-030749 |
| 2026-09-17Filed 2026-09-18 | Taffe Norman POfficer · President Generac HomeFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1 | M Exercise / conversionCommon Stock · Non-derivative | 150A | 119.54 | Direct | Form 4 ↗0001437749-26-030749 |
| 2026-09-17Filed 2026-09-18 | Raabe Kyle AndrewOfficer · President, Home Power Gen.Filing contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 05-05-2026 F2 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F2 | M Exercise / conversionStock Option (Right to Buy) · Derivative | 213D | 0 | Direct | Form 4 ↗0001437749-26-030747 |
| 2026-09-17Filed 2026-09-18 | Raabe Kyle AndrewOfficer · President, Home Power Gen.Filing contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 05-05-2026 F2 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 213D | 229.5 | Direct | Form 4 ↗0001437749-26-030747 |
| 2026-09-17Filed 2026-09-18 | Raabe Kyle AndrewOfficer · President, Home Power Gen.Filing contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 05-05-2026 F2 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1 | M Exercise / conversionCommon Stock · Non-derivative | 213A | 102.415 | Direct | Form 4 ↗0001437749-26-030747 |
| 2026-09-17Filed 2026-09-18 | Raabe Kyle AndrewOfficer · President, Home Power Gen.Filing contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 05-05-2026 F2 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 390D | 229.5 | Direct | Form 4 ↗0001437749-26-030747 |
| 2026-09-08Filed 2026-09-09 | Taffe Norman POfficer · President Generac HomeFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F3 | M Exercise / conversionStock Option (Right to Buy) · Derivative | 100D | 0 | Direct | Form 4 ↗0001437749-26-030003 |
| 2026-09-08Filed 2026-09-09 | Taffe Norman POfficer · President Generac HomeFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 100D | 190 | Direct | Form 4 ↗0001437749-26-030003 |
| 2026-09-08Filed 2026-09-09 | Taffe Norman POfficer · President Generac HomeFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1 | M Exercise / conversionCommon Stock · Non-derivative | 100A | 119.54 | Direct | Form 4 ↗0001437749-26-030003 |
| 2026-09-08Filed 2026-09-09 | Taffe Norman POfficer · President Generac HomeFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 100D | 188.27 | Direct | Form 4 ↗0001437749-26-030003 |
| 2026-09-08Filed 2026-09-09 | Taffe Norman POfficer · President Generac HomeFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1, F2 | S Sale (market/private)Common Stock · Non-derivative | 200D | 188.27 | Direct | Form 4 ↗0001437749-26-030003 |
| 2026-09-01Filed 2026-09-03 | Taffe Norman POfficer · President Generac HomeFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | F WithholdingCommon Stock · Non-derivative | 3,932D | 181.22 | Direct | Form 4 ↗0001437749-26-029645 |
| 2026-09-01Filed 2026-09-02 | Jagdfeld AaronDirector · Officer · Chief Executive OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 12-04-2025 References: F1 | S Sale (market/private)Common Stock · Non-derivative | 5,000D | 182.21 | Direct | Form 4 ↗0001437749-26-029526 |
| 2026-08-07Filed 2026-08-10 | Raabe Kyle AndrewOfficer · President, Home Power Gen.Filing contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 05-05-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date Exercisable will vary for each vesting tranche. References: F3 | M Exercise / conversionStock Option (Right to Buy) · Derivative | 213D | 0 | Direct | Form 4 ↗0001437749-26-026804 |
| 2026-08-07Filed 2026-08-10 | Raabe Kyle AndrewOfficer · President, Home Power Gen.Filing contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 05-05-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date Exercisable will vary for each vesting tranche. References: F1, F2 | S Sale (market/private)Common Stock · Non-derivative | 213D | 213.35 | Direct | Form 4 ↗0001437749-26-026804 |
| 2026-08-07Filed 2026-08-10 | Raabe Kyle AndrewOfficer · President, Home Power Gen.Filing contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 05-05-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date Exercisable will vary for each vesting tranche. References: F1 | M Exercise / conversionCommon Stock · Non-derivative | 213A | 102.415 | Direct | Form 4 ↗0001437749-26-026804 |
| 2026-08-07Filed 2026-08-10 | Raabe Kyle AndrewOfficer · President, Home Power Gen.Filing contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 05-05-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date Exercisable will vary for each vesting tranche. References: F1, F2 | S Sale (market/private)Common Stock · Non-derivative | 373D | 213.35 | Direct | Form 4 ↗0001437749-26-026804 |
| 2026-08-05Filed 2026-08-06 | Taffe Norman POfficer · President Generac HomeFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F3 | M Exercise / conversionStock Option (Right to Buy) · Derivative | 100D | 0 | Direct | Form 4 ↗0001437749-26-026286 |
| 2026-08-05Filed 2026-08-06 | Taffe Norman POfficer · President Generac HomeFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F3 | M Exercise / conversionStock Option (Right to Buy) · Derivative | 150D | 0 | Direct | Form 4 ↗0001437749-26-026286 |
| 2026-08-05Filed 2026-08-06 | Taffe Norman POfficer · President Generac HomeFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1, F2 | S Sale (market/private)Common Stock · Non-derivative | 100D | 218.39 | Direct | Form 4 ↗0001437749-26-026286 |
| 2026-08-05Filed 2026-08-06 | Taffe Norman POfficer · President Generac HomeFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1 | M Exercise / conversionCommon Stock · Non-derivative | 100A | 119.54 | Direct | Form 4 ↗0001437749-26-026286 |
| 2026-08-05Filed 2026-08-06 | Taffe Norman POfficer · President Generac HomeFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 150D | 220 | Direct | Form 4 ↗0001437749-26-026286 |
Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.